This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.

Sponsored by Sheba Medical Center

About this trial

Last updated 15 years ago

Study ID

SHEBA-07-4859-OG-CTIL

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 35 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 15 years ago

What is this trial about?

Sickle cell anemia and Sickle cell β thalassemia patients require multiple transfusions in order to avoid chronic anemia sequel. This regimen entails intrinsic deleterious effects, the majority of which are related to iron deposition in the reticuloendothelial system. Thus, iron is deposited in hepatic, myocardial and endocrine glands tissues. Tools available for iron load evaluation include serum ferrtin levels, liver biopsy and echocardiography, all are non specific. The purpose of this work is to compare iron overload in the liver, heart and pancreas in Sickle cell anemia and Sickle cell β thalassemia patients using T2* MRI sequences.

What are the participation requirements?

Yes

Inclusion Criteria

- clinical diagnosis of Sickle cell anemia or Sickle cell β thalassemia having received multiple blood transfusions.

No

Exclusion Criteria

- contraindication to MRI

Locations

Location

Status